Juergen Srega - Sep 2, 2021 Form 4 Insider Report for BRUKER CORP (BRKR)

Role
Group President Bruker CALID
Signature
Sara Hussain, Attorney-in-Fact
Stock symbol
BRKR
Transactions as of
Sep 2, 2021
Transactions value $
-$14,332,253
Form type
4
Date filed
9/3/2021, 04:02 PM
Previous filing
Aug 9, 2021
Next filing
Aug 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BRKR Common Stock Options Exercise $1.67M +90K +62.99% $18.57 233K Sep 2, 2021 Direct
transaction BRKR Common Stock Options Exercise $525K +25.4K +10.89% $20.68 258K Sep 2, 2021 Direct
transaction BRKR Common Stock Options Exercise $702K +35.4K +13.72% $19.82 294K Sep 2, 2021 Direct
transaction BRKR Common Stock Options Exercise $876K +39.5K +13.44% $22.19 333K Sep 2, 2021 Direct
transaction BRKR Common Stock Sale -$18.1M -202K -60.7% $89.54 131K Sep 2, 2021 Direct F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BRKR Stock Option (Right to Purchase) Options Exercise $0 -90K -100% $0.00* 0 Sep 2, 2021 Common Stock 90K $18.57 Direct F1
transaction BRKR Stock Option (Right to Purchase) Options Exercise $0 -25.4K -100% $0.00* 0 Sep 2, 2021 Common Stock 25.4K $20.68 Direct F2
transaction BRKR Stock Option (Right to Purchase) Options Exercise $0 -35.4K -100% $0.00* 0 Sep 2, 2021 Common Stock 35.4K $19.82 Direct F3
transaction BRKR Stock Option (Right to Purchase) Options Exercise $0 -39.5K -100% $0.00* 0 Sep 2, 2021 Common Stock 39.5K $22.19 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option granted to the Reporting Person on April 3, 2013 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
F2 The stock option granted to the Reporting Person on August 8, 2014 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
F3 The stock option granted to the Reporting Person on August 7, 2015 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
F4 The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.5014 to $90.15, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.